Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
11/2010
11/10/2010EP2247592A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247590A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
11/10/2010EP2247184A1 Dual pharmacophores-pde4-muscarinic antagonistics
11/10/2010CN101883774A Thienopyrimidine and pyrazolopyrimidine compounds and their use as MTOR kinase and PI3 kinase inhibitors
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/03/2010EP2246351A1 Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device
11/03/2010EP2245033A1 Pyrrolopyrazine kinase inhibitors
11/03/2010EP2244577A1 Quinolizidinone m1 receptor positive allosteric modulators
11/03/2010CN1980938B Mitotic kinesin inhibitors
11/03/2010CN101878216A Pyrimidine derivatives as protein kinase inhibitors
11/03/2010CN101293892B Biapenem dimer and preparation method thereof
11/03/2010CN101115760B Pyrrolopyrazoles, potent kinase inhibitors
11/02/2010CA2455416C Vinca alcaloids preparations process and their derivatives
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/2010
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/27/2010EP2243783A1 Bisporphyrin conjugates as two photon absorption materials
10/27/2010EP2243782A2 Two-photon absorption material and application thereof
10/27/2010EP2041145B1 Azatricyclic compounds and their use
10/27/2010CN101874032A Novel naphthyridine derivative monohydrate and method for producing the same
10/27/2010CN101870705A Novel organic compound, light-emitting device, and image display apparatus
10/26/2010CA2457053C Preventive agent/remedial agent for constipation predominant ibs
10/21/2010WO2010120996A1 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010120991A1 5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/20/2010EP2241567A1 Bicycloamine derivative
10/20/2010EP2240494A1 Thieno-pyridine derivatives as mek inhibitors
10/20/2010CN101868464A Thienopyrimidiene derivatives as PI3k inhibitors
10/20/2010CN101863909A Norcantharidin derivative and activity testing method and application thereof
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/19/2010US7816530 cis- or trans-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine; antiinflammatory and antiproliferative activity; antiviral and anticarcinogenic agent
10/19/2010US7816519 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
10/19/2010US7816398 Fatty alcohol drug conjugates
10/14/2010WO2010118207A1 Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors
10/13/2010EP2239320A1 Nerve trunk cell propagation accelerator
10/13/2010EP2238140A2 Substituted heteroarylamide diazepinopyrimidone derivatives
10/13/2010CN101861316A Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
10/13/2010CN101857603A Multi-stage countercurrent extraction method for azadirachtin
10/13/2010CN101245081B Novel cephalosporin derivative
10/12/2010US7812014 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
10/12/2010CA2419552C Substituted pyrazoles
10/07/2010WO2010114900A1 Substituted indolo-piperidine compounds
10/07/2010CA2756808A1 Substituted indolo-piperidine compounds
10/06/2010EP2235010A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
10/06/2010CN101851238A Substituted 8-heteroaryl xanthines
10/05/2010US7807671 viricides such as 1-(7-bromo-4-fluoro-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-(4-(1-phenyl-1H-tetrazol-5-yl)piperazin-1-yl)ethane-1,2-dione , used for the treatment of HIV and AIDS
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
09/2010
09/30/2010WO2010111406A2 Compounds and therapeutic uses thereof
09/30/2010WO2010110026A1 Pharmaceutical composition for metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2231667A2 Beta-lactamase inhibitors
09/29/2010EP1727817B1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2010CN1965052B Single-layer organic el device
09/29/2010CN101845054A Bis-triazolothiadiazole compounds containing 1,2,3-thiadiazole and preparation method and application thereof
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010CA2382247C Azaindoles having serotonin receptor affinity
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/22/2010EP2229393A2 3-substituted-4-oxo-3,4-dihydro-imidazo-[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides as anticancer agents
09/22/2010EP1765830B1 Mitotic kinesin inhibitors
09/22/2010EP1682549B1 Imidazo[1,2-a]pyridine anxiolytics
09/22/2010EP1490374B1 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
09/21/2010US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799524 methods of transferring a label from novel substrates to O6-alkylguanine-DNA alkyltransferases (AGT) and O6-alkylguanine-DNA alkyltransferase fusion proteins, and to novel substrates suitable in such methods
09/21/2010CA2470832C Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/15/2010EP2228375A1 New xanthin derivatives, their production and utilisation as medicine
09/15/2010EP1751156B1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
09/15/2010CN101835779A Purine derivatives useful as PI3 kinase inhibitors
09/15/2010CN101337972B Process for extracting vincaleuucoblastine from vinca
09/14/2010US7795307 acetylcholinesterase inhibitors, comprising prodrugs of an amphetamine and a methamphetamine compounds, used for treating Alzheimer's disease
09/14/2010CA2434834C 6-substituted pyrido-pyrimidines
09/10/2010WO2010101230A1 Quinoxaline compounds
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754457A1 Quinoxaline compounds
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/09/2010US20100227843 Beta-lactamase-resistant cephalosporin ester compounds and salts of thereof
09/08/2010EP2224920A1 Process for making macrocyclic oximyl hepatitis c protease inhibitors
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN101827853A Heterocycle-substituted piperazino-dihydrothienopyrimidines
09/08/2010CN101827852A Substituted piperidino-dihydrothienopyrimidines
09/08/2010CN101824163A Process for preparing a synergistic stabilizer mixture
09/08/2010CN101235046B Novel vinblastine derivative, preparation method and use thereof, and medical composition containing the derivative
09/07/2010US7790740 administering chemokine receptor antagonist such as N-{(1S)-3-[3-endo-(5-Acetyl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-(-3-fluorophenyl)propyl}acetamide, for the treatment of viral, bacterial and protozoa infections
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
09/02/2010WO2010098367A1 Pyrimidopyrimidoindazole derivative
09/02/2010WO2010098246A1 Organic electroluminescent element
09/02/2010WO2010097410A1 Novel bronchodilating diazaheteroaryls
09/02/2010US20100222378 2-heteroarylcarboxylic acid amides
09/02/2010CA2750716A1 Pyrimidopyrimidoindazole derivative
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010CN101821268A Tetracyclic compounds for the treatment of hepatitis c
09/01/2010CN101821217A Method of separating isomers of chiral substances and apparatus therefor
09/01/2010CN101817837A Carbapenem derivative containing azabicyclo
09/01/2010CN101817825A Bi-dihydroxy ethylene urea, derivatives, preparation method and application thereof
08/2010
08/31/2010US7786299 Methods for treating diseases or conditions using dihydropteridinone compounds
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 111